Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-hepatic Oxaliplatin + Gem/Cap + Cetuximab in Cholangiocarcinoma
NCT01247337Phase 2Completed
- Start
- Feb 2011
- Primary completion
- Feb 2016
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, KL-140 in cholangiocarcinoma (CCA), gallbladder cancer. Started Feb 2011; status: completed.
02
Drugs
oxaliplatinKL-140
03
Conditions
cholangiocarcinoma (CCA)gallbladder cancer
Beyond the preview
Go deeper on NCT01247337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01247337.